Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in adolescents with homozygous familial hypercholesterolemia (HoFH) and elevated low density lipoprotein cholesterol (LDL-C).
Epistemonikos ID: 0381197c5e9c5159d5080deaa1cdc010aaa37f67
First added on: May 08, 2024